Journals / Eurasian Journal of Medicine / 2022 / Cilt: 54 - Sayı: 1

Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model

Pages
36–40
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Considering other characteristics such as Algan hemostatic agent’s naturalness, easy applicability, and low cost, Algan hemostatic agent has been a promising effective hemostatic agent.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Major vascular injury is one of the most important causes of death after trauma.
📊
Key Findings & Data:Materials and Methods: A total of 28 rats were used in the study.
💡
Conclusion & Impact:Considering other characteristics such as Algan hemostatic agent’s naturalness, easy applicability, and low cost, Algan hemostatic agent has been a promising effective hemostatic agent.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Major vascular injury is one of the most important causes of death after trauma. The effective and speedy control of the hemorrhage is crucial in reducing deaths. Many products are used for this purpose. Today, however, an ideal product has not yet been produced and there is a strong demand for such effective hemostatic products. The aim of this study is to compare the efficacy of Algan hemostatic agent with Floseal in the liver laceration model in rats. Materials and Methods: A total of 28 rats were used in the study. Rats were divided into 4 groups, each consisting of 7 rats. Experimental liver laceration was established. In the control group, saline-impregnated gauze was applied. Algan hemostatic agent-impregnated sponge, Algan hemostatic agent powder, and Floseal gel were applied to the experimental groups. Results: There was no difference in bleeding control among the Algan hemostatic agent powder, Algan hemostatic agent-impregnated sponge, and Floseal. When compared to the control group, Algan hemostatic agent powder, Algan hemostatic agent-impregnated sponge, and Floseal were found to be very effective in bleeding control, respectively (P=.001, .012, and .002), in the experimental groups. Conclusion: This study showed that the properties of both Algan hemostatic agent powder and Algan hemostatic agent-impregnated sponge for controlling bleeding are similar to Floseal. Considering other characteristics such as Algan hemostatic agent’s naturalness, easy applicability, and low cost, Algan hemostatic agent has been a promising effective hemostatic agent.

🔖

Cite This Article

BİNNETOĞLU, K., KUMANDAŞ, A., EKİCİ, H., ÖZBAYKUŞ, A. C. (2022). Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model. Eurasian Journal of Medicine, Cilt: 54 - Sayı: 1, 36–40. https://ajindex.com/articles/508770

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Parks RW, Chrysos E, Diamond T. Management of liver trauma. Br J Surg. 1999;86(9):1121-1135. [CrossRef] 2. Champion HR, Bellamy RF, Roberts CP, Leppaniemi A. A profile of combat injury. J Trauma. 2003;54(5):S13-S19. [CrossRef] 3. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38(2):185-193. [CrossRef] 4. Wu WC, Trivedi A, Friedmann PD, et al. Association between hospital intraoperative blood transfusion practices for surgical blood loss and hospital surgical mortality rates. Ann Surg. 2012;255(4):708-714. [CrossRef] 5. Huri E, Akgül KT, Yücel MÖ, Astarcı HM, Üstün H, Germiyanoğlu RC. The second step in vitro trial of Ankaferd® Bloodstopper®: comparison with other hemostatic agents. Turk J Med Sci. 2011;41(1):7-15. 6. Hanks JB, Kjaergard HK, Hollingsbee DA. A comparison of the haemostatic effect of Vivostat® patient-derived fibrin sealant with oxidised cellulose (Surgicel®) in multiple surgical procedures. Eur Surg Res. 2003;35(5):439-444. [CrossRef] 7. Akarsu C, Kalaycı MU, Yavuz E, et al. Comparison of the hemostatic efficiency of Ankaferd Blood Stopper and fibrin glue on a liver laceration model in rats. TJTES. 2011;17:308-312. 8. Aysan E, Kilic K, Kinaci E, Basak F, Caliskan YK. Efficacy of “aluminium sulphate” in prevention of hepatic parenchymal bleeding. Turk J Surg. 2004;20:147-152. 9. Midi A, Kumandas A, Ekici H. Investigation of the efficacy of Algan hemostatic agent in liver laceration model in rats. EJMO. 2019;3(1):37-42. [CrossRef] 10. Satar NYG, Akkoc A, Oktay A, Topal A, Inan K. Evaluation of the hemostatic and histopathological effects of Ankaferd Blood Stopper in experimental liver injury in rats. Blood Coagul Fibrinolysis. 2013;24(5):518-524. [CrossRef] 11. Aysan E, Bektas H, Ersoz F, Sari S, Kaygusuz A, Huq GE. Ability of the Ankaferd blood stopper® to prevent parenchymal bleeding in an experimental hepatic trauma model. Int J Clin Exp Med. 2010;3(3):186-191. 12. Fonouni H, Kashfi A, Majlesara A, et al. Hemostatic efficiency of modern topical sealants: comparative evaluation after liver resection and splenic laceration in a swine model. J Biomed Mater Res B Appl Biomater. 2018;106(3):1307- 1316. [CrossRef] 13. Ramirez MG, Deutsch H, Khanna N, Cheatem D, Yang D, Kuntze E. FloSeal only versus in combination in spine surgery: a comparative, retrospective hospital database evaluation of clinical and healthcare resource outcomes. Hosp Prac (1995). 2018;46(4):189-196. [CrossRe